Rebook & Win: Dinner & a Movie

November 1, 2016 at 9:56 am


Register to donate blood, platelets, plasma, or red cells in November and rebook your next appointment before you leave to be entered to win two gift cards: one $50 Red Robin gift card and one $25 Fandango gift card.

It’s a perfect night out!

One entry per donor and we will pull the drawing winners on December 2. One winner at every donor center.

Make your appointment at or by calling us at 1-800-398-7888

Kevin’s story: blood donation and BBQ

September 1, 2016 at 4:13 pm



Meet Kevin Jones and his girlfriend, Debbie. Kevin is a double red cell donor at BloodworksNW’s Olympia Donor Center.

Kevin came in to present us with a donation of $1113 today! Kevin puts on fundraising events, and this year he chose BloodworksNW as the recipient of money raised at the Annual Greasy Biker & Neighbor BBQ.

The Greasy Biker & Neighbor BBQ started in Kevin’s backyard, but the event grew. Past attendees wanted to camp out overnight. And thought a band and bike show would be great too.

Today, it’s an extravaganza of bikes, beer, and BBQ pork, chicken, steamers, and oysters.

Kevin believes in BloodworksNW’s mission, and always wants to do good for his community. A couple of years ago, Kevin raised funds for a friend who was undergoing cancer treatment. His friend had a single-income family, and Kevin wanted to do something to alleviate some of their financial stresses.

Kevin’s generosity will go towards our fundraising efforts for a new Mini Bus in Olympia. He is happy to know that the money will help community blood drives in Mason and Thurston counties.

Thank you, Kevin!

Your financial contributions make a difference! Make a gift online.

Doubling the odds: Gina’s cord blood story

August 15, 2016 at 2:13 pm

gina-healthyIn the summer of 2012, Gina Grein was constantly tired. She thought it was from working two jobs and needing extra rest. In November, Gina noticed a large bruise on her calf, but figured she had just run into something. Her sister had been diagnosed with Chronic Myelogenous Leukemia (CML), and Gina’s focus was on her sister’s health.

Her dentist even noticed that her gums had even changed color, but they felt perhaps a change in toothpaste was to blame. It seemed to go away.

Everything was explainable. I had never been sick in my life.

On New Year’s Eve, Gina went to the grocery store and barely made it home. She recalls sitting down on the couch and waking up six hours later.

Over the next few days, she could hardly eat or get out of bed. It’s the flu, she thought, but a weird flu. After a few days of calling in late or being sent home from work, she asked a friend to take her to the doctor.

Gina’s bloodwork showed a 50% blood loss, but she still thought she had caught a virus.

The doctor said, ‘I don’t think you have the flu. Go to the ER.’ I was like, ‘how can I have a blood loss with the flu?’

She received four blood transfusions over the next four days.

A bone marrow biopsy confirmed the worst: acute myeloid leukemia (AML). Gina was released from the hospital in Puyallup, and sent to Seattle Cancer Care Alliance (SCCA) the next day.

The prognosis wasn’t great: SCCA oncologists gave her 10 months to live with no treatment, and a 39% chance of survival with standard chemo.

But there was another option: adding a trial drug called “the hedgehog” might up her odds of beating AML to 70%. She would be the first patient at UW on this regimen.


Gina was hospitalized at UW Medical Center a for seven days straight, with around-the-clock IV chemo. She received more than five months of treatment.

Thanks to the chemo and “the hedgehog,” her AML went into remission for a year but returned.

Doctors put her onto another trial drug. She did’t feel sick as she had been before, but her blood counts were down to zero.

A stem cell transplant would be Gina’s only hope of a cure.

She received blood transfusions every two to three days while doctors looked for a bone marrow match.

Siblings have a 25% chance of matching a patient’s human leukocyte antigen (HLA), the marker that helps your immune system determine what belongs in your body and what’s an invader. Out of Gina’s five siblings, only two were eligible to be considered. One was a partial HLA match, and one was a zero HLA match. There were no qualified unrelated donors in the bone marrow database.

Then her UW physicians decided on a novel procedure: a double cord blood transplant. Gina would receive cord blood from two donors to increase her odds of success.

Cord blood units can successfully engraft with an HLA match that is less exact than the matches required for a bone marrow transplant from adult donors, resulting in lower probability of graft versus host disease.

On December 13, 2014 Gina checked into UW Medical Center for five rounds of chemo and one round of head-to-toe radiation to kill off her bone marrow and immune system, and the next day received two units of cord cells from two anonymous infant boys.

The transplant itself took 40 minutes, 20 minutes per unit. It’s no different from getting blood – the recovery part is the hard part.

Gina now shares an immune system with baby boy #2, and likens recovery to stepping back to infancy:

Every childhood shot is gone, so it’s hard for people to understand that I can’t be around sick people. Chicken pox, measles - I don’t have an immunity to those any more.

Twenty months later, she’s in remission with no evidence of disease. Rebuilding her immune system has been harder than she imagined, but her energy is coming back and she’s excited that she’s able to work a few hours a week at her local Home Depot.

Gina has nothing but gratitude. She feels fortunate to live in an area with outstanding medical facilities like UW Medicine and SCCA.

She’s grateful to the local blood donors who sustained her during her treatment, and to the infant boys – now toddlers – who allowed her to live.

I think about those donors every day, and their parents. I wish you could  write a note to the parents, but I just feel grateful that cord blood donation is now starting to have the awareness that it can to save somebody’s life, because without that I wouldn’t be here right now.

Meet BloodworksNW’s summer interns!

August 5, 2016 at 8:32 am

Meet our 2016 summer volunteer interns! These talented, bright students have been a great addition to BloodworksNW, and are enjoying learning about research, healthcare, fundraising, and other aspects of our organization.


Katherine (L) and Christine (R) are volunteering on our Development team! They’re sisters (triplets, actually) who will be seniors at Bellevue High School in the fall. Along with their brother, they were born prematurely, and Christine needed a blood transfusion. They’re organizers of Music for Life: A Concert Benefiting Bloodworks Northwest, and are both excited to learn more about fundraising, communication and leadership skills, and how medical technology is used to help the community. Their BloodworksNW supervisors say that it’s such a pleasure to be working with such quick and dedicated learners!


Neha is a Regulatory Affairs student interning with our Materials Management department! She’s inspired by BloodworksNW’s lifesaving work and is excited to be part of this team. Being a Regulatory Affairs student, she also wants to learn about the regulations, clinical research, and quality system management that BloodworksNW uses in maintaining the quality of biologics, blood products, and providing excellent health care services, and is hoping to jump start her career in the healthcare industry.

Use-Avina 2

Avina is a Business student at the University of Washington! She’s helping Washington Center for Bleeding Disorders with medical records and reporting this summer. She admires Bloodworks’ commitment to serving diverse communities, and is most excited to learn more about how data is stored, analyzed, and used to summarize populations. When she’s not in school or at Bloodworks, she enjoys attending on-campus cultural events, finding new places to eat, and competing against her family in Mario Party.


Holt is a Biostatistician Intern at Bloodworks Research Institute in the Johnsen lab! He’s a junior Physics major at Carleton College interested in pursuing a career in medicine. He’s also a volunteer at our Bellevue donor center, and is most excited about learning how to do meta-analyses at the Biostatistics Core this summer. In addition to coding statistical analyses in R, Holt has been in the lab optimizing a polymerase chain reaction (PCR).


Jesse is a future executive helping our CEO’s office archive board records this summer! He’s a straight ‘A’ student and a captain of the water polo team at Bellevue high school. He also volunteers as a donor monitor and helps organize Music for Life: A Concert Benefiting Bloodworks Northwest, an annual student-run concert. His goal for the summer is to learn how decisions are made in upper management and how he can best contribute.


Eleanor is dedicated to improving the lives and well-being in local communities! As a Business Operations Intern at Bloodworks Research Institute​, she’s building the foundation for her future career in public health: she plans on earning a master’s degree in public health so that she can combine research and service to the community. She’s excited be involved in research to promote positive health outcomes for people as well as the process of creating and implementing solutions for issues in the community.

We’ll be sorry to say goodbye when their internships end on August 26!

Learn more about our Summer Volunteer Internship Program.

Sickle Cell Disease and blood transfusions

June 17, 2016 at 9:00 am


Sickle cell disease (SCD) is a chronic genetic blood disorder inherited from both parents. Having sickle cell trait (inheriting the gene from one parent but not the other) is an advantage against malaria, which is why SCD primarily impacts people of African, Mediterranean, Middle Eastern, and Indian descent.

But the disease itself (which happens when someone inherits genes from both parents) is devastating.

When someone has SCD, their red blood cells are shaped like stiff crescents instead of flexible discs. These pointed cells can snag on blood vessel walls, causing blockages that prevent oxygen from reaching tissues, incredible pain (called a crisis), and damage to a patient’s brain, eyes, internal organs, joints, bones, and skin. These complications can be life-threatening.

Approximately 1 in 500 African Americans (100,000 people in the U.S) have SCD, though as many as 1 in 13 African Americans are carriers of sickle cell trait.

Treatment of SCD often includes chronic blood transfusion therapy to increase the number of healthy red blood cells in the bloodstream, even when a patient is not actively sick. Transfusions can reduce the chance of stroke.

Says Bloodworks Research Institute’s Dr. James Zimring,

The more we study the disease, the more we understand that transfusions are needed earlier and more frequently than we have appreciated.

Anyone who receives regular blood transfusions is at risk of developing antibodies against antigens in other people’s blood, called alloimmunization. The more antibodies someone makes, the harder it becomes to find blood they can still receive.

Transfusion for transfusion, patients with SCD are more likely to develop antibodies than someone without it. Although science is working hard on it, no one understands all of the reasons why.

Most of us know that our blood type is either A, B, O or AB, and Rh positive or negative, which correspond to antigens on the red cells, but there are actually hundreds of other antigens in the blood.

Dr. Meghan Delaney, BloodworksNW’s Medical Director for Transfusion Service at Seattle Children’s, says:

When sickle cell pediatric patients get transfusions from our blood bank. they require specially matched red cells. Most patients receive blood that’s matched for ABO and Rh,

Other than matching blood to patients, there is no way to prevent a reaction besides not transfusing. For some patients, this can to lead delays, substandard care, and even death.

BloodworksNW’s Immunohematology & Red Blood Cell Genomics Reference Laboratory performs the extended blood typing and matching for patients in the community. Sickle cell patients also have blood typing done by genotype, or molecular methods, since there tends to be blood group differences in people of different ethnic backgrounds that can make figuring different blood types more complicated.

Dr. Zimring explains:

Antigens tend to be within an ethnic group. You are more likely to be a match to someone who has a similar ancestry as you do. Therefore, the more people who have a similar ancestry that donate blood, the more likely it is that  compatible blood will be available.

Dr. Zimring hopes to uncover why SCD patients are so difficult to transfuse. He and BloodworksNW’s Dr. Krystalyn Hudson are studying the process by which the immune system makes antibodies to transfused red blood cells.

Understanding why sickle cell patients make antibodies at a greater frequency might help scientists understand why any patient might make an antibody.

This awareness will help researchers formulate new therapeutic approaches, which will help both sickle cell patients and others receiving regular transfusions.

One thing is for certain:

Sickle cell disease would benefit from increased resources for delivery of medical care and research.

More donors of all ethnic backgrounds are needed to help patients in our community. Schedule your next donation

Switch to our mobile site